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ABSTRACT
Developmental control of bone tissue-specific genes requires positive
and negative regulatory factors to accommodate physiological require-
ments for the expression or suppression of the encoded proteins. Osteo-
calcin (OC) gene transcription is restricted to the late stages of osteoblast
differentiation. OC gene expression is suppressed in nonosseous cells and
osteoprogenitor cells and during the early proliferative stages of bone cell
differentiation. The rat OC promoter contains a homeodomain recogni-
tion motif within a highly conserved multipartite promoter element (OC
box I) that contributes to tissue-specific transcription. In this study, we
demonstrate that the CCAAT displacement protein (CDP), a transcription
factor related to the cut homeodomain protein in Drosophila melanogaster,
may regulate bone-specific gene transcription in immature proliferating
osteoblasts. Using gel shift competition assays and DNase I footprinting,
we show that CDP/cut recognizes two promoter elements (TATA and OC
box I) of the bone-related rat OC gene. Overexpression of CDP/cut in ROS
17/2.8 osteosarcoma cells results in repression of OC promoter activity;
this repression is abrogated by mutating OC box I. Gel shift immunoas-
says show that CDP/cut forms a proliferation-specific protein/DNA com-
plex in conjunction with cyclin A and p107, a member of the retinoblas-
toma protein family of tumor suppressors. Our findings suggest that
CDP/cut may represent an important component of a cell signaling mech-
anism that provides cross-talk between developmental and cell cycle-
related transcriptional regulators to suppress bone tissue-specific genes
during proliferative stages of osteoblast differentiation.
INTRODUCTION
Bone tissue formation occurs late in fetal development and is
mediated by osteoblasts that secrete bone-related extracellular matrix
proteins (e.g., collagen type I and OC3) that support mineral deposi-
tion (1, 2). The temporal appearance and location of preosseous
tissues is controlled in part by homeodomain transcription factors and
developmental morphogens (3–5). The classical Hox homeodomain
proteins represent 13 paralogous classes of related proteins, which
share a 60-amino acid protein segment (homeobox) that contacts DNA
(6, 7). Several Hox genes (e.g., Hoxa-10, Hoxa-11, and Hoxa -13, as well
as Hoxd-10, Hoxd-11, Hoxd-12, and Hoxd-13) participate in the forma-
tion of axial and appendicular skeletal elements (3). However, whereas
Hox and other developmental mediators primarily control positional
information along the anterior/posterior body axis, osteoblast maturation
appears to involve other classes of (“non-Hox”) homeodomain proteins
that are expressed at later stages of fetal development. For example,
expression of the Dlx-5 and Msx-2 homeodomain proteins is cell type
restricted and confined to specific stages of skeletal development and
bone cell differentiation. Furthermore, mutations in the Msx-2 and Dlx-5
genes have been implicated in genetic skeletal abnormalities (8, 9). Both
transcription factors are capable of repressing bone tissue-related gene
expression (10–14) and are differentially expressed during osteoblast
differentiation. These data suggest that Dlx-5 and Msx-2 represent tissue-
specific components of a homeodomain-mediated signaling cascade that
may determine the progression of osteoprogenitors into mature osteocytic
cells. Although the activities of Msx-2 and Dlx-5 appear to control bone
tissue-specific genes during late developmental stages, other homeodo-
main proteins may regulate osteoblast-related genes during earlier stages
of osteoblast phenotype commitment.
Osteogenesis proceeds by developmental transitions of pluripotent
progenitor cells of mesenchymal origin into precommitted osteopro-
genitor cells that eventually mature into osteoblasts that support the
extracellular matrix (1, 2). Osteoblast differentiation in vitro proceeds
by a three-stage developmental sequence and occurs concomitantly
with formation of a mineralized bone-like extracellular matrix similar
to bone in vivo (1, 2). The OC gene represents a paradigm for
understanding transcriptional control of osteoblast maturation (15).
The OC gene is transcriptionally inactive in nonosseous cells and
immature osteoprogenitor cells. The gene is up-regulated during os-
teoblast differentiation when osteoblasts cease to divide and is ex-
pressed maximally in mineralizing osteoblasts. Because OC is a major
noncollagenous bone protein and biosynthesis is primarily restricted
to mature mineralizing osteoblasts, expression of the OC gene appears
to be positively and negatively controlled to accommodate physiolog-
ical requirements for the encoded protein in mineralized bone. One
principal tissue-specific element of the OC promoter regulating these
transcriptional modulations is a multipartite transcriptional element
designated OC box I. Both Msx-2 and Dlx-5 functionally interact with
a homeodomain motif (59-CTAATT) that overlaps a CCAAT-like
element within OC box I (10–14). Because Dlx-5 and Msx-2 are not
expressed in many nonosseous cells, we postulate that OC gene
transcription may be in part actively repressed by general rather than
tissue-specific transcription factors.
CDP/cut is a ubiquitous homeodomain protein homologous to the
Drosophila cut gene (16–18) and represents an active repressor of
differentiation-specific gene expression in many vertebrate cell types
(19–27). CDP/cut contains four conserved DNA binding domains,
i.e., three cut repeats and a single homeodomain, which each recog-
nize redundant but related sequence elements (28, 29), including
CCAAT and TAAT motifs identical to those present in OC box I of
the rat and mouse OC genes (10, 11). In addition, interactions of
CDP/cut with gene promoters can occur in conjunction with pRB and
related tumor suppressor proteins (27, 30, 31). Hence, CDP/cut may
represent an important component of a cell signaling mechanism that
provides cross-talk between developmental and cell growth-related
transcriptional regulators. Despite these interesting biological proper-
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Fig. 1. Summary of DNA probes, oligonucleotides, and OC promoter mutations. The top portion shows a schematic representation of the OC promoter including key gene-regulatory
elements as described in detail previously (15). The proximal promoter contains a series of regulatory elements including the TATA box and OC box I, as well as sites for
AML/CBFA-related runt-homology proteins (Site C), HLH proteins (E-box), and the glucocorticoid receptor (GRE). OC box I is a principal tissue-specific element that contains a
CCAAT-like motif (59-CCAAT, sense strand) and an overlapping homeodomain recognition motif (59-TCAATT, antisense strand; Refs. 11 and 12). The DNA probe used for
protein/DNA interaction studies is indicated immediately below the OC promoter diagram and spans nt 2140/123 (Pst/HindIII fragment). OC promoter oligonucleotides used as
specific competitor DNAs in this study are indicated by lines with arrowheads. The OC 99/76 MUT oligonucleotide contains an 8-nt mutation (box with vertical stripes) in which the
59-CCAATTAG element is mutated to 59-GACTGCTC. Additional oligonucleotides containing established CDP/cut binding sites (lines with arrowheads on each end) were derived
from the promoters of the gp91phox (17, 22), histone H4 (34, 36), and histone H3 (51) genes. Key regulatory elements (boxes with diagonal stripes) and relevant promoter domains
(horizontal brackets) for each of these genes are indicated to show the relative locations of CDP/cut sites. DNase I footprints for CDP/cut have been established for all four promoters
and are indicated by thick lines above the sequences (the DNase I footprint data for the OC gene were determined as a component of this study and are presented in Fig. 3). Relevant
motifs related to CCAAT and TATA boxes that are located within the DNase I footprints for each gene are indicated with arrows below the sequences.
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ties, functional involvement of CDP/cut in regulating osteoblast-
related gene expression has not been explored.
In this study, we show that CDP/cut functionally interacts with OC
box I and the TATA box and is capable of repressing OC promoter
activity. Furthermore, our data demonstrate that CDP/cut interacts
with the OC promoter in a proliferation-specific manner and forms a
higher order protein/DNA complex with the pRB-related protein p107
and cyclin A. Therefore, in a broader context, these data may provide
support for the concept that the CDP/cut homeodomain protein is a
component of an intricate transcriptional mechanism that suppresses
differentiation-specific gene expression in actively dividing cells by
forming specific protein/DNA complexes with cell growth regulatory
factors.
MATERIALS AND METHODS
Protein/DNA Interaction Assays. Nuclear proteins from ROS 17/2.8 os-
teosarcoma cells and calvarial rat osteoblasts were obtained by salt extraction
(0.42 M KCl; Ref. 32) using a procedure that has been documented in detail
previously (33). Nuclear extracts from HeLa cells were prepared as described
previously (34). The bacterially expressed GST/CDP (CR2-Cterm) fusion
protein (17) was purified using glutathione-resin as described by the manu-
facturer (Pharmacia). All protein preparations were quantitated by Coomassie
Blue dye binding assays.
Gel shift assays with nuclear extracts were performed as described previ-
ously (34) in a volume of 20 ml and contained 10 fmol of a 32P-labeled DNA
fragment spanning the promoters of the genes for rat OC (nt 2140/123;
PstI/HindIII fragment of pOCZCAT; Ref. 11), human histone H4 (nt 297/
238; EcoRI/HindIII fragment of pFP201; Ref. 34), or human gp91phox (nt
2136/276; EcoRI/HindIII fragment of pFPUC; Ref. 17). Binding reactions
with nuclear extract protein contained 2 mg of poly(G/C) DNA and 0.2 mg of
poly(I/C) DNA, whereas reactions with purified GST/CDP(CR2-Cterm) con-
tained 0.2 mg of poly(G/C) DNA. Standard competition assays were performed
by adding a 100-fold molar excess (1 pmol) of unlabeled oligonucleotides to
the DNA probe before adding protein. Gel shift immunoassays were performed
as described previously (27) with antibodies against p107 and p130 (Santa
Cruz Biotechnology) or with hybridoma supernatants and antisera as indicated
in the figure legends. Gel shift assays aimed at determining the molecular
weight of the CDP/cut protein/DNA complexes were performed as described
by Orchard and May (35) using a-macroglobulin as a standard. To facilitate
measurements (in mm) of the migration of the CDP/cut complex in gel shift
assays, electrophoresis times were extended to a total of 4–8 h at 200 V.
DNase I footprinting analyses of GST/CDP(CR2-Cterm) binding were
performed with probes that were labeled at an artificial HindIII site (nt 123)
present in pOCZCAT (11) using either [32P]g-ATP and T4 polynucleotide
kinase (for labeling the antisense strand) or [a-32P]dCTP and Klenow polym-
erase (for labeling the sense-strand). Binding reactions were performed with
the GST/CDP(CR2-Cterm) protein in a 50-ml volume using 10 fmol of probe
and 500 ng of poly(G/C) DNA. DNase I digestions were performed by diluting
samples to 100 ml while adding DNase I (1 Kunitz unit) and MgCl2 (5 mM,
final concentration). Reactions were allowed to proceed for 1 min at ambient
temperature (20°C) and terminated by the addition of 50 ml of stop-mix (10
mM EDTA, 0.1% SDS, and 0.2 mg/ml salmon sperm DNA). Samples were then
subjected to phenol/chloroform extraction, followed by ethanol precipitation.
DNA pellets were quantitated by Cerenkov counting and dissolved in 90%
formamide. Samples were electrophoresed in sequencing gels and analyzed by
autoradiography.
Transient Expression Assays. Functional evaluation of the effects of
CDP/cut on OC promoter activity was performed in ROS 17/2.8 osteosarcoma
cells by cotransfecting a CMV promoter-driven construct containing the full-
length CDP/cut cDNA (17) with wild-type or mutant OC promoter/CAT fusion
construct (11) using calcium phosphate-mediated gene transfer (32). Variation
in transfection efficiency was accounted for by cotransfecting a SV40 promot-
er-driven luciferase construct. Samples were harvested 2 days after transfection
and evaluated for CAT and luciferase activity. CAT values were normalized
for luciferase activity and evaluated by ANOVA of repeated measures for
statistical significance (P , 0.01; Dr. Stephen Baker, University of Massa-
chusetts Biocomputing Department, Worcester, MA).
RESULTS
The CDP/cut Homeodomain Protein Interacts Specifically with
the Proximal Promoter of the OC Gene. The proximal promoter of
the rat OC gene (Fig. 1) contains at least one CCAAT-like element
and a 59-TCAATT homeodomain motif, both of which reside in OC
box I, a principal tissue-specific promoter element of the OC gene (1).
Both elements are among a variety of sequence motifs recognized by
CDP/cut (28, 29). We directly addressed the question of whether
CDP/cut is capable of interacting with the proximal OC promoter.
Binding of purified recombinant GST-CDP/cut fusion protein [GST/
CDP(CR2-Cterm)] was assessed in gel shift assays using a probe
spanning nt 2140 to 123 of the OC gene (Fig. 2A). In addition, we
analyzed the binding of endogenous CDP/cut complexes in nuclear
extracts from ROS 17/2.8 osteosarcoma cells (Fig. 2B). The GST/
CDP(CR2-Cterm) protein mimics the DNA binding properties of the
full-length CDP/cut protein and spans the COOH-terminal portion of
CDP/cut, encompassing cut repeats 2 and 3 and the homeodomain
(22). As a positive control, we used a probe spanning the duplicated
CCAAT box region of the myeloid gp91-phox gene that represents a
prototypical high affinity CDP/cut site (Refs. 17 and 19; data not
shown). The results show that the GST/CDP(CR2-Cterm) fusion
protein (Fig. 2A) and endogenous CDP/cut proteins (Fig. 2B) form
electrophoretically stable complexes with the OC gene promoter.
To establish specificity of the CDP/cut protein/DNA interactions,
we performed gel shift competition assays with a panel of oligonu-
cleotides (Fig. 1) spanning wild-type and mutant sequences of the OC
promoter that encompass the OC box. DNA segments comprising
previously characterized binding sites in the gp91-phox (17, 19) and
histone H4 and histone H3 genes4 (27) were also analyzed. The data
show that complexes mediated by recombinant GST/CDP(CR2-
Cterm) protein (Fig. 2A) and endogenous CDP/cut proteins (Fig. 2B)
with the OC probe (nt 2140/123) are competed by OC promoter
segment nt 2120/276. In contrast, the OC segment nt 299/276
competes with very low efficiency. No competition is observed with
a mutant oligonucleotide OC nt 299/276, which contains mutations
in OC box I that alter the overlapping CCAAT and CTAATT motifs.
These findings suggest that the interaction of CDP/cut with the OC
gene requires the CCAAT/homeodomain motif of OC box I and
adjacent sequences between nt 2120 and 276.
For comparison, the site in the gp91-phox gene that binds CDP/cut
with very high affinity (estimated kd 5 10-11 M; Ref. 22) competes
strongly for recombinant GST/CDP(CR2-Cterm) binding to the OC
gene. Segments spanning the promoters of the histone H4 (estimated
kd 5 1029 M)4 and histone H3 genes compete with moderate efficiency
(Fig. 2B). Comparison of the oligonucleotide competition data sug-
gests that the relative strength of GST/CDP(CR2-Cterm) binding to
different genes is gp91-phox .. OC . H4 . H3.
DNase I footprinting results (see the data presented below) indicate
that both OC promoter regions are important for binding. Competition
experiments using ROS 17/2.8 nuclear proteins were also performed
with wild-type and OC box mutant nt 2120/276 oligonucleotides
(OC 120/76), as well as with wild-type and mutant oligonucleotides
spanning nt 250 to 26 of the OC promoter that encompasses the
TATA box region (OC 50/6; Fig. 2C). The competition data (Fig. 2C)
show that the OC 120/76 and OC 50/6 oligonucleotides both compete
for CDP/cut binding, albeit with modest efficiency, but the corre-
sponding mutant oligonucleotides show reduced competition poten-
tial. We then performed gel shift experiments with the wild-type OC
120/76 and OC 50/6 oligonucleotides in comparison to the plasmid-
derived OC 2140/123 fragment (OC 140/123) as probes (Fig. 2D).
4 Unpublished data.
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Using nuclear protein from ROS 17/2.8 cells under stringent condi-
tions to suppress the binding of nonspecific proteins present in nuclear
extracts, i.e., using relatively high nonspecific DNA amounts [2 mg of
poly(G/C) DNA and 200 ng of poly(I/C) DNA] per 20 ml reaction),
we observed the formation of an electrophoretically stable complex
containing CDP/cut only for the 2140/123 fragment (OC 140/123)
and not for either of the 45-mer oligonucleotides (OC 120/76 and OC
50/6; Fig. 2D, top panel). Gel shift experiments were performed in
parallel using GST/CDP(CR2-Cterm) protein (Fig. 2D, lower panel).
We note that these binding reactions with affinity-purified protein are
performed with less nonspecific DNA [200 ng of poly(G/C) DNA] than
used with nuclear extracts, because there are few nonspecific proteins
Fig. 2. Sequence-specific binding of CDP/cut to the OC promoter. A, gel shift assays were performed with purified recombinant GST-CDP/cut fusion protein [GST/CDP(CR2-
Cterm)] to a probe spanning nt 2140/123 of the OC gene (top and bottom panels). Oligonucleotide competition analysis of GST/CDP-Cterm binding to the OC probe was performed
using increasing amounts of unlabeled competitor DNA oligonucleotides (sloped triangle). The amounts added were, respectively, 0, 1, 2, or 5 pmol of oligonucleotide per lane. Because
each reaction contains 10 fmol (0.5 nM) of probe, these amounts correspond with, respectively, 0-, 100-, 200-, and 500-fold molar excess of unlabeled competitor oligonucleotide. The
oligonucleotides span portions of the OC gene promoter (top panel) or the promoters of the histone H4, gp91-phox, and histone H3 genes (bottom panel). The OC 99/76 mut fragment
contains an 8-nt mutation of the internal region of the OC box that abolishes the overlapping CCAAT-like element and CTAATT homeodomain motif (11, 12). The OC probe mediates
both high (p) and low (pp) mobility complexes with recombinant CDP/cut protein. The high mobility complexes increase with increasing amounts of protein (data not shown) and may
reflect binding of more than one CDP protein per probe molecule. B, gel shift oligonucleotide competition assays were performed with nuclear protein (3 mg) from ROS 17/2.8 cells
and the OC probe (nt 2140/123) using the same increasing amounts of competitor DNA oligonucleotides (sloped triangle) as described in A. The double arrowhead indicates the
endogenous CDP/cut complex that appears as a closely spaced doublet. The origin of electrophoretic migration is just above the border of the panel. The results show that endogenous
CDP/cut complexes in osteoblast and osteosarcoma cells have a binding specificity similar to that of recombinant GST/CDP/cut. We note that the electrophoretic mobilities of
endogenous CDP/cut protein/DNA complexes (B) are significantly slower than those mediated by recombinant CDP/cut protein (A); the difference in mobility may be due to the absence
or presence of cofactors (see Fig. 5). C, oligonucleotide competition assays were performed using the OC promoter fragment nt 2140/123 as a probe and 45-mer oligonucleotides
spanning the wild-type or mutant OC box I region from nt 2120 to 276 (OC 120/76) or the TATA box region from nt 250 to 26 (OC 50/6). These experiments were performed
using approximately 6 mg of ROS 17/2.8 nuclear protein, and the sloped triangle represents increased competitor quantities (0, 2.5, 5, and 10 pmol, respectively). We note that the
CDP/cut complex is detected as a single band (rather than a doublet, see B) in these assays, which may be due to subtle differences in experimental procedures. D, gel shift assays
were carried out with ROS 17/2.8 nuclear protein (6 mg; top panel) and recombinant GST/CDP(CR2-Cterm protein) (lower panel) using radiolabeled OC promoter fragments spanning
nt 2140 to 123 (OC 140/123), 2120 to 276 (OC 120/76) and 250/26 (OC 50/6), as well as a probe spanning a CDP/cut binding site in the histone H4 gene (52).
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present. Under these more relaxed binding conditions, we observed that
the full-length OC 2140/123 promoter probe mediates the expected
strong binding of CDP, but CDP also exhibits weak binding to the
radiolabeled OC 120/76 and OC 50/6 oligonucleotides (Fig. 2D, lower
panel). Thus, whereas the ability to detect low-affinity interactions of
CDP/cut with the 45-mers is influenced by the stringency of the binding
reactions, the formation of electrophoretically stable CDP/cut complexes
is significantly increased when the full-length OC promoter fragment nt
2140/123 (OC 140/123) is used in gel shift assays.
Interestingly, the TATA box oligonucleotide nt 250/26 spans the
segment of the OC promoter that is more strongly protected from
DNase I in the presence of CDP/cut than the OC box region (see
below). However, either oligonucleotide is relatively inefficient in
forming electrophoretically stable protein/DNA complexes (Fig. 2D)
and in competition for protein binding (Fig. 2C). These findings
suggest that efficient binding of CDP/cut with the OC promoter
requires that the OC box and TATA box regions are linked within the
same DNA fragment.
The Tissue-specific OC Box and the Basal Transcription-
related TATA Box in the OC Gene Are Recognition Targets for
CDP/cut Binding. To determine the sites of interaction of CDP/cut
with the rat OC promoter, we performed DNase I footprinting anal-
yses on the sense and antisense strands (Fig. 3). On both strands, two
DNase I protected regions were observed in the presence of recom-
binant GST/CDP(CR2-Cterm) protein. Region 1 (nt 2100/281,
sense; nt 2112/282, anti-sense; Fig. 3) overlaps OC box I nt 299/
276. This result corroborates the results of the oligonucleotide com-
petition assays (Fig. 2) that suggest that OC box I is important for
CDP/cut binding. Rat OC box I, which contains a binding site for the
Msx-2 (11) and Dlx-5 (13) homeodomain proteins (59-CCAATTAG;
nt 292/285), may provide a recognition motif for the homeodomain
portion of CDP/cut (28). Region 2 (nt 239/211, sense; nt 237/211,
anti-sense) encompasses the TATA box of the OC gene. Because the
GST/CDP(CR2-Cterm) protein contains three intrinsic DNA binding
domains (a single homeodomain and two cut repeats, i.e., cut 2 and cut
3), protection of the TATA box may reflect interactions of secondary
DNA binding domains within the same CDP/cut molecule. However,
equally viable is the possibility that a second CDP/cut protein may
associate with the OC promoter, as suggested by the formation of putative
oligomeric GST/CDP(CR2-Cterm) complexes with the OC promoter
(Fig. 2). Based on gel shift data (see Fig. 2, C and D), efficient binding
of CDP/cut occurs only when the OC box I and TATA box regions are
present within the same DNA fragment. Because CDP/cut specifically
recognizes the OC box I and TATA box element of the rat OC gene, it
appears that CDP/cut targets two key elements essential for tissue-
specific basal levels of OC gene transcription (1).
CDP/cut Represses OC Gene Transcription, Which Requires
the CCAAT/Homeodomain Motif of the OC Box. To assess the
functional consequences of CDP/cut interactions with the OC pro-
moter in osseous cells, we performed transient cotransfection exper-
iments with the full-length CDP/cut protein and an OC promoter/CAT
reporter gene construct in ROS 17/2.8 osteosarcoma cells (Fig. 4).
Normal diploid osteoblasts do not transcribe the OC gene during
proliferative stages. However, ROS 17/2.8 osteosarcoma cells display
abrogation of cell growth and differentiation interrelationships result-
ing in basal transcription of the bone differentiation-specific OC gene
(1). Because nonosseous cells do not activate the OC promoter and
putative trans-activators that operate via OC-box I remain to be
identified (10–14), ROS 17/2.8 cells represent a viable cell culture
model for assaying repressive effects of CDP expression on OC
promoter activity.
Transient expression of CDP/cut in ROS 17/2.8 cells reduces OC
promoter activity by approximately 2-fold, which is significant as
determined by computer-assisted statistical evaluation using ANOVA
(P , 0.01). In contrast, expression of CDP/cut does not influence OC
promoter activity when the CCAAT/homeodomain motif of OC box I
is mutated. We conclude that CDP/cut specifically represses OC gene
transcription by direct interactions with the OC promoter involving
OC box I.
Although loss of CDP/cut repression is abrogated by the OC box I
mutation, this result does not preclude a role for the CDP/cut recog-
nition motif in the TATA box region. However, assessing the relative
importance of the TATA box within the context of the native OC
promoter is technically difficult because of the overlap between the
CDP/cut site and the TATA element that is required for transcriptional
initiation. In an extensive series of studies with the histone H4 gene in
which CDP/cut (also known as HiNF-D) interacts with CAAT and
TATA-like elements, we have not been able to design subtle muta-
Fig. 3. CDP/cut binds to the TATA box and OC box of the OC gene. DNase I
footprinting reactions were performed with the sense (left) and antisense strands (right) in
the absence (CTRL) or presence (CDP) of GST/CDP(CR2-Cterm) protein. Electrophoresis
of DNase I-digested samples was performed in parallel with a chemical sequence ladder
(G-rxn). The locations of representative guanine residues in the OC promoter (e.g., G69)
are indicated by arrowheads. DNase I protected regions reflected by reduced DNase I
cleavage in the presence of protein are indicated by f along the autoradiograms. M, areas
of uncertainty in determining footprint boundaries due to bp preferences of DNase I and
infrequent cleavage of sequences near OC box I. Differences in the relative strength of the
DNase I footprints for the sense versus antisense strand may be due to experimental
variation in probe quantity and specific activity related to the labeling procedure (T4
kinase versus Klenow polymerase). However, similar results were obtained in three
separate experiments, and the locations of footprints on the sense and antisense strands
occur within overlapping regions of the OC promoter.
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tions that abolish CDP/cut binding but do not affect binding of the
TATA-binding protein (Refs. 34 and 36 and references therein). Thus,
the role of the TATA region in CDP/cut-dependent regulation of OC
gene expression remains to be established.
Results from gel shift immunoassays indicate that p107 and cyclin
A interact with CDP/cut (see the data presented below). To assess
whether these cofactors can influence OC promoter activity, we
performed two independent transfection experiments in triplicate in
which CDP/cut was coexpressed with p107 or cyclin A in osteoblastic
ROS 17/2.8 cells to evaluate responsiveness of the wild-type and
mutant OC promoter (data not shown). The results indicate that
expression of p107 or cyclin A does not influence OC promoter
activity and does not affect suppression by CDP/cut. These findings
suggest that the endogenous levels of p107 and cyclin A are not
rate-limiting for the activity of CDP/cut in this cell type. Consistent
with this suggestion, we have not been able to detect CDP/cut con-
taining protein/DNA complexes at the OC promoter that lack p107 or
cyclin A by gel shift assays (data not shown).
CDP/cut Interacts in Conjunction with the pRB-related Protein
p107 and Cyclin A to Form a Large (Mr > 340,000) Protein/DNA
Complex at the OC Gene Promoter. Nuclear proteins from ROS
17/2.8 cells mediate a closely spaced gel shift doublet representing
two types of protein/DNA complexes in 4% (80:1) polyacrylamide
gels (Figs. 2B and 5), although the resolution of this doublet is
dependent on experimental conditions (e.g., see Fig. 2C). The very
low mobility of these complexes is a signature property of CDP/cut
complexes isolated from mammalian cells (16, 27). Preincubation of
nuclear proteins from ROS 17/2.8 cells with a polyclonal CDP/cut
antibody (16, 17) results in inhibition of CDP/cut binding to the OC
promoter (Fig. 5A). No immunoreactivity is observed with control
antisera (nonimmune or preimmune guinea pig serum; Fig. 5A and
data not shown). These data establish that there are at least two types
of CDP/cut complexes in ROS 17/2.8 cells.
We have previously shown that CDP/cut protein/DNA complexes
with cell cycle-controlled histone H4, H3, and H1 genes contain a
pRB-related protein and cyclin A (27, 30). We assessed whether
CDP/cut interactions with the OC promoter involve similar higher
order protein/DNA complexes. Gel shift immunoassays were per-
formed using antibodies against the pRB-related proteins p130 and
p107 (Fig. 5B), as well as cyclin A (Fig. 5A). Nuclear proteins from
ROS 17/2.8 cells were preincubated with specific polyclonal antibod-
ies directed against COOH-terminal residues of p107 or p130. The
results show quantitative formation of a ternary antibody/protein/
DNA complex (“supershift”) at the OC promoter in the presence of
the p107 antibody, but not in the presence of the p130 antibody (Fig.
5B). In addition, CDP/cut complexes with the OC promoter are
completely inhibited in the presence of a monoclonal cyclin A anti-
body, but not in the presence of a control hybridoma supernatant (Fig.
5A). Thus, the immunoreactivity of CDP/cut complexes at the OC
promoter with p107 and cyclin A antibodies indicates that CDP/cut
forms higher order protein/DNA complexes in conjunction with p107
and cyclin A.
We determined whether CDP/cut complexes with p107 are unique
to osseous cells or the bone-related OC promoter. We directly com-
pared immunoreactivity of CDP/cut complexes with p107 antibodies
using nuclear proteins from ROS 17/2.8 osteosarcoma and HeLa
cervical carcinoma cells with DNA probes spanning the promoters of
the OC and myeloid gp91phox gene (Fig. 5C). The results demon-
strate that CDP/cut complexes from both osseous (ROS 17/2.8) or
nonosseous (HeLa) cells form supershift complexes in the presence of
the p107 antibody with probes spanning the proximal promoters of
either the OC or gp91phox gene. For comparison, we have previously
shown that CDP/cut complexes with cell cycle-controlled histone H4,
H3, and H1 genes are immunoreactive with a panel of monoclonal
antibodies against pRB, but not with antibodies against p107 or p130
(27). Therefore, formation of CDP/cut complexes with pRB-related
proteins is not unique to osteoblastic cells and appears to be promoter
selective.
As a technical note, the ability of antibodies to show immunoreac-
tivity in gel shift assays is dependent on intrinsic properties of the
antibody (e.g., titer, avidity, and specificity for native protein) and
protein/DNA complex (e.g., accessibility of the epitope and confor-
mation of the protein on DNA). Gel shift immunoassays monitoring
interactions of cyclins and pRB-related proteins with CDP/cut have
been performed with distinct cyclin A antibodies and a series of
different pRB-related antibodies (see Refs. 27, 30, and 31). Immuno-
reactivity of the CDP/cut complex at the OC gene promoter in gel
shift assays was only observed with the p107 antibody (SC-X-318)
used in this study. However, this same antibody does not shift the
CDP/cut complex observed for the histone H4 gene involving a
pRB(p105) interaction with CDP/cut (27), which demonstrates the
molecular specificity of the p107 antibody. Further definition of
protein/protein interactions of CDP/cut with cyclin A and pRB-related
proteins and the involvement of DNA recognition in modulating these
interactions is currently under way.
To begin assessing the size of the CDP/cut complex on the OC
promoter (2140/123), we performed molecular weight analysis in
gel shift assays according to the method of Orchard and May (35).
This method involves parallel electrophoresis of the CDP/cut complex
and a series of protein molecular weight markers in polyacrylamide
gels with different percentages (Fig. 5D). CDP/cut protein/DNA com-
plexes migrate very slowly (,5 mm/h) in standard 4% (80:1) poly-
acrylamide gels. For comparison, we have previously shown that
higher order E2F protein/DNA complexes (containing pRB and cyclin
A) have a much higher mobility (.20 mm/h) than CDP/cut protein/
DNA complexes under very similar experimental conditions (31). The
mobility of CDP/cut in gels of different polyacrylamide concentra-
tions is significantly lower than that of all protein markers tested,
including a-macroglobulin (Mr 340,000; Fig. 5D). Furthermore, CDP/
cut protein/DNA complexes are virtually immobilized at the origin of
Fig. 4. Transient cotransfection analysis of CDP/cut effects on OC gene transcription.
Transfection experiments were performed with a CMV construct driving the expression of
the full-length CDP/cut protein and OC promoter/CAT reporter gene in ROS 17/2.8
osteosarcoma cells. The wild-type OC/CAT construct (pOCZCAT) spans 1.1-kb of the
59-flanking region, and the mutant OC/CAT construct is based on pOCZCAT but contains
an 8-nt mutation in OC box I that abrogates the CTAATT homeodomain motif (11). Each
bar graph represents the average values of CAT activity corrected for luciferase activity
(internal standard) of three independent experiments, each performed in triplicate, with the
indicated amount of CMV/CDP construct. Statistical significance (P , 0.01) of CDP/cut
effects on the wild-type but not the mutant OC promoter activity was established by
ANOVA.
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migration when the percentage of polyacrylamide is increased to 4.8%
(constant cross-linking ratio of 80:1 acrylamide to bis-acrylamide;
Fig. 5D) or when the cross-linking ratio is increased from 80:1 to 20:1
(constant polyacrylamide percentage of 4%; Ref. 34). Taken together,
these data suggest that CDP/cut forms macromolecular protein/DNA
complexes that are considerably larger than Mr 340,000.
Endogenous CDP/cut Complexes in Osseous Cells Are Prolif-
eration-specific and Down-Regulated at the Cessation of Cell
Growth. The association of cell growth-regulatory factors p107 and
cyclin A with CDP/cut complexes at the OC promoter suggests that
these complexes may be restricted to dividing cells. We assessed
whether endogenous CDP/cut complexes with the OC promoter are
regulated in relation to proliferation. The levels of CDP/cut binding
activity were examined in normal diploid ROB osteoblasts and ROS
17/2.8 osteosarcoma cells during the proliferative period and postpro-
liferatively in confluent cell cultures. Similar to ROS 17/2.8 cells,
ROB cells display two CDP/cut complexes (Fig. 6A), which are
specifically competed by a wild-type CDP/cut binding site oligonu-
cleotide (Fig. 6B). The level of the CDP/cut complex with reduced
mobility is high in proliferating normal diploid ROB cells and ROS
Fig. 5. Osteoblast-related CDP/cut complexes contain p107 and cyclin A. A, gel shift
immunoassays were performed using ROS 17/2.8 nuclear proteins (3 mg) that were
preincubated with polyclonal CDP/cut guinea pig antiserum (17), nonimmune guinea pig
serum (a non-i), control hybridoma supernatant (hyb.sup.), and monoclonal cyclin A
hybridoma supernatant; Lanes CTRL and C represent standard binding reactions in the
absence of antibodies. The left panel shows results obtained for binding reactions
containing the OC probe, and the right panel shows the results obtained for binding
reactions with the gp91-phox probe for comparison. Immunoreactivity is reflected by
inhibition of the CDP/cut complex. The last three lanes of the left panel represent a
competition assay with unlabeled DNA fragments (1 pmol) spanning wild type (Lane S,
TM-3) and mutant (Lane N, NH-6) CDP/cut binding sites that were established previously
(34). These competition assays were routinely performed as parallel reactions to confirm
sequence-specific binding of CDP/cut in our assays. B, same as A, using increasing
amounts (sloped triangle; 0, 1, 2, and 4 ml of antibody, respectively) of polyclonal
antipeptide antibodies directed against p130 (C-20, SC-X-317; Santa Cruz Biotechnology)
and p107 (C-18, SC-X-318; Santa Cruz Biotechnology). The double arrowhead indicates
the CDP/cut-complex (doublet), and a 1 C points at the supershift complex
of CDP/cut and the p107 antibody. C, same as in B, using the OC and gp91-phox probes
in combination with nuclear protein from human HeLa S3 cells and rat ROS 17/2.8 cells.
D, the relative molecular weight of CDP/cut protein/DNA complexes was analyzed by the
method of Orchard and May (35). The relative mobility (vertical axis) of the CDP/cut
complex (F) was determined by autoradiography, and the relative mobility of the protein
marker (a-macroglobulin, Mr 340,000; M) was detected by Coomassie Blue staining after
electrophoresis in polyacrylamide gels with different percentages (3.6–4.8% polyacryl-
amide with a cross-linking ratio of 80:1 acrylamide to bis-acrylamide), as indicated on the
horizontal axis. The results show that the CDP/cut complex is substantially larger than the
Mr 340,000 protein marker and is virtually immobilized at the origin of migration in high
percentage gels (e.g., 4.8%). These properties are consistent with CDP/cut forming a high
molecular weight protein/DNA complex.
Fig. 6. Endogenous CDP/cut complexes in osteoblast-related cells are most abundant
in proliferating cells. A, gel shift assays using nuclear protein (3 mg) from proliferating
(D3) and postproliferative (D14) ROB cells, as well as proliferating (D3) and confluent
(D8) ROS 17/2.8 cells incubated with the OC probe. Double arrowheads indicate the
positions of the CDP/cut complexes. B, gel shift competition assays demonstrating the
sequence specificity of the CDP/cut complexes shown in A using nuclear protein from
ROB (D3) and ROS 17/2.8 (D3) cells. Competition assays were performed with a
100-fold excess (1 pmol) of oligonucleotides (37) spanning wild-type (Lane S, TM-3) and
mutant (Lane N, NH-6) CDP/cut binding sites.
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17/2.8 osteosarcoma cells but barely detectable in confluent ROB and
ROS 17/2.8 cells (Fig. 6A). Similarly, CDP/cut complexes with the
gp91-phox and histone H4 genes are detectable at high levels only in
proliferating ROB and ROS 17/2.8 cells.
To control for quantitation and integrity of the nuclear protein
preparations, this same panel of ROS 17/2.8- and ROB-derived nu-
clear protein preparations was also evaluated for levels of several
other transcription factors including SP-1, YY-1, ATF, AP-1, and
AML-3/CBFA1-related DNA binding activities (data not shown; see
Ref. 33). In these assays, we observed that the levels of SP-1 and
AML are highest in nondividing ROB and ROS 17/2.8 cells. The
levels of YY-1- and ATF-related proteins were not significantly
different between proliferating and nonproliferating cells. Further-
more, modulations in the levels of AP-1 activity were found to parallel
those of CDP/cut complexes (33). Thus, it appears that the levels of
CDP/cut complexes with pRB-related proteins and cyclin A are se-
lectively down-modulated at the cessation of cell proliferation.
DISCUSSION
In this study, we have shown that the ubiquitous homeodomain
transcription factor CDP/cut interacts with two separate recognition
motifs (OC box I and TATA box) in the proximal promoter of the
bone-related OC gene. Gel shift immunoassay data indicate that
CDP/cut forms proliferation-specific complexes with cell growth-
regulatory factors p107 and cyclin A on the OC promoter. Further-
more, using transient cotransfection assays, we have shown that
CDP/cut is capable of transcriptionally repressing the differentiation-
specific OC gene in osteoblastic cells, which requires sequences in rat
OC box I. We note that the rat, mouse, and human OC genes display
differences in transcriptional regulation (37–39). These differences
are reflected by subtle nucleotide variations in the sequences spanning
OC box I and the TATA box in the three species. The conservation of
the functional role of CDP/cut in OC gene expression in these three
species remains to be addressed.
The repression of OC gene promoter activity by the CDP/cut
homeodomain protein extends previous observations indicating that
two other non-Hox homeodomain proteins, Msx-2 (10, 11) and Dlx-5
(13, 14), can repress OC gene transcription via the homeodomain
recognition element of OC box I. The physiological role for each of
these factors in transcriptional control of osteoblast-specific genes
must be addressed. Differentiation of precommitted but immature
osteoblasts into mature and mineralizing osteocytic cells in culture
occurs by a multistage developmental sequence characterized by
modifications in gene expression of developmental stage-specific
markers (e.g., histone H4, alkaline phosphatase, osteopontin, and OC;
Ref. 1). The role of Msx-2 in osteoblast differentiation is indicated by
results showing that: (a) Msx-2 is expressed in vivo at several loca-
tions involving epithelial/mesenchymal interactions (40, 41); (b) mu-
tations in the Msx-2 gene result in craniosynostosis (8); (c) antisense
inhibition of Msx-2 in calvarial osteoblasts prevents osteoblast mat-
uration (12); and (d) maximal expression of Msx-2 is restricted to
proliferating osteoblasts and is down-regulated at the maturation
transition (11). Functional involvement of Dlx-5 in osteoblast matu-
ration is suggested by the following observations: (a) Dlx-5 and Dlx-6 are
the only Dlx family members expressed in the perichondral region of
developing fetal skeletal elements (42, 43); and (b) Dlx-5 gene expression
is dramatically up-regulated at the onset of extracellular matrix mineral-
ization in calvarial osteoblast cultures (13). Differences and similarities in
expression of Dlx-5 and Msx-2 in vivo may accommodate ossification of
different skeletal elements and are consistent with a role for Msx-2 and
Dlx-5 in progression of osteoblast differentiation.
In contrast to the tissue-specific roles of Msx-2 and Dlx-5 in skeletal
differentiation, CDP/cut and related factors are involved in transcriptional
suppression of differentiation-specific marker genes in a broad spectrum
of tissues and cell types (17, 19–27). Although high-level expression of
CDP/cut is restricted to specific regions during embryonic or fetal devel-
opment in vivo (44–48), CDP/cut DNA binding activity can be detected
in a plethora of proliferating cells in vertebrates (summarized in Refs.22
and 34). The proliferation-specific nature of CDP/cut protein/DNA com-
plexes and the association of CDP/cut with cell growth-regulatory factors
p107 and cyclin A in a large (Mr . 340,000) multimeric complex binding
to the bone-related OC promoter suggest that CDP/cut may represent a
general suppressor of tissue-specific gene expression in response to cell
cycle-regulatory signals.
It has been well established that a subset of the E2F class of cell
cycle-regulatory transcription factors forms complexes with p107 and
cyclin A. Recently, we have shown that CDP/cut is the DNA binding
subunit of the histone gene-regulatory protein HiNF-D that contains
cyclin A and a pRB-related protein as auxiliary subunits (27, 30). The
interaction of CDP/cut with the cell cycle-related proteins p107 and
cyclin A as components of transcription factor complexes at the
differentiation-specific OC and gp91-phox promoters observed in this
study suggests a novel and CDP/cut-dependent role for pRB-related
proteins in gene regulation. Interestingly, Webster et al. (49) have
presented data suggesting that the development of uterine leiomyomas
in transgenic mice expressing the polyomavirus-encoded large T
antigen (a known pRB-binding protein) may be causally related to
molecular interactions between large T, pRB, and CDP/cut. Further-
more, Wiggan et al. (50) have observed interactions between p107
and paired-like homeodomain proteins (e.g., MHox and Pax-3). Thus,
interactions of pRB-related proteins with distinct classes of homeodo-
main proteins may represent a general mechanism for coupling cell
growth-related signals with developmental cues regulating tissue-
specific gene expression.
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